Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Autor: Anders Själander, Johan Lanng Nielsen, Henrik Hjorth-Hansen, Satu Mustjoki, Kari Remes, Hans Ehrencrona, Ole Weiss Bjerrum, Anders Almqvist, Mats Björeman, Berit Markevärn, Fredrik Sandin, Franz Gruber, Kristina Myhr-Eriksson, Claes Malm, Max Flogegard, Arnon Nagler, V Kairisto, Ulla Strömberg, Perttu Koskenvesa, Anders Lindblom, Kimmo Porkka, Karin Olsson, Marjatta Sinisalo, Jesper Stentoft, Tobias Gedde-Dahl, Bengt Simonsson, Lotta Ohm, Anu Räsänen

Publikováno v: Simonsson, B, Gedde-Dahl, T, Markevärn, B, Remes, K, Stentoft, J, Almqvist, A, Björeman, M, Flogegård, M, Koskenvesa, P, Lindblom, A, Malm, C, Mustjoki, S, Myhr-Eriksson, K, Ohm, L, Räsänen, A, Sinisalo, M, Själander, A, Strömberg, U, Bjerrum, O W, Ehrencrona, H, Gruber, F, Kairisto, V, Olsson, K, Sandin, F, Nagler, A, Nielsen, J L, Hjorth-Hansen, H, Porkka, K & Nordic CML Study Group 2011, ' Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low-or intermediate-risk chronic myeloid leukemia ', Ironic Blood, vol. 118, no. 12, pp. 3228-35 . https://doi.org/10.1182/blood-2011-02-336685

Biologic and clinical observations suggest that combining imatinib with IFN-α may improve treatment outcome in chronic myeloid leukemia (CML). We randomized newly diagnosed chronic-phase CML patients with a low or intermediate Sokal risk score and i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9674851dfcdb18ca880ccd2a0c5a7e59
https://doi.org/10.1182/blood-2011-02-336685

The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties

Autor: H. Steensland, Adam Uldall, P Felding, V. Kairisto, L Franzson, P. Hyltoft Petersen, Arto Lahti, Per Simonsson, Arne Mårtensson, P Rustad

Publikováno v: Scandinavian Journal of Clinical and Laboratory Investigation. 64:271-284

Each of 102 Nordic routine clinical biochemistry laboratories collected blood samples from at least 25 healthy reference individuals evenly distributed for gender and age, and analysed 25 of the most commonly requested serum/plasma components from ea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46f396dedfc1889a581160dbb3e507c
https://doi.org/10.1080/00365510410006324

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Method for determining reference changes from patients' serial data: example of cardiac enzymes

Autor: V. Näntö, Liisa-Maria Voipio-Pulkki, A Virtanen, Esa Uusipaikka, Kerttu Irjala, O Peltola, V Kairisto

Publikováno v: Clinical Chemistry. 39:2298-2304

Changes between serial laboratory test results can be significant, even if none of the individual results exceeds the reference interval. We developed a statistical method for the calculation of reference change limits from routine patients' data for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::da7a1c9b062c16adef61dac00a5869f4
https://doi.org/10.1093/clinchem/39.11.2298

Quality Control of Multichannel Hematology Analyzers: Bivariate On-line Comparison of MCV and MCH Values for the Detection of Random Errors

Autor: V. Näntö, Arja Virtanen, Esa Uusipaikka, Timo Kouri, Allan Rajamäki, V Kairisto

Publikováno v: American Journal of Clinical Pathology. 97:645-651

Volume and hemoglobin content of red blood cells are physiologically interdependent variables but are measured independently in multichannel hematologic analyzers. Therefore correlation of these results to each other can be used as an additional step

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5a9f616e10fbd6704ff9c860126c07
https://doi.org/10.1093/ajcp/97.5.645